DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated...
216 insider purchases on record · latest filing 2025-11-10.
Insiders have also filed 2,037 sale transactions at DXCM.